1-7 of 7
Andrew Saunders
Close
Sort by
Journal Articles

Activation of Fc Gamma Receptor-Dependent Responses to Therapeutic Antibodies By Nurse like Cells Requires PI3Kdelta

Yu-Chen Enya Chen, BSc, Melinda Lea Burgess, Antje Blumenthal, PhD, Sally Mapp, Peter Mollee, FRACP, FRCPA, MBBS, MMSc, Devinder Gill, Nicholas Andrew Saunders, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3128.
https://doi.org/10.1182/blood-2018-99-109719
Published: 2018
Journal Articles

A Phase II Open-Label, Multi-Center Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab (KW-0761) in Patients with Previously Treated Peripheral T-Cell Lymphoma(PTCL)

Pier Luigi Zinzani, Bertrand Coiffier, MD PhD, John Radford, Dolores Caballero, Paul Fields, MD PhD, Martine ED Chamuleau, MD, Francesco d'Amore, Corinne Haioun, MD PhD, Catherine Thieblemont, MD PhD, Eva González Barca, MD PhD, Carlos Grande García, MD, Peter W Johnson, MD, Gustaaf W van Imhoff, MD PhD, Andrew Saunders, MD, Karen Dwyer, Franck Morschhauser, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1763.
https://doi.org/10.1182/blood.V124.21.1763.1763
Published: 2014
Journal Articles

Acadesine for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL): A Multicentre Phase I/II Study

Eric Van den Neste, Bruno Cazin, Ann Janssens, M.D., Eva González-Barca, María José Terol, Vincent Levy, Jaime Pérez de Oteyza, Pierre Zachee, Andrew Saunders, Mercè de Frias, Clara Campàs
Journal: Blood
Blood (2010) 116 (21): 4625.
https://doi.org/10.1182/blood.V116.21.4625.4625
Published: 2010
Journal Articles

Screening Thousands of Drugs in Leukemia Patient Samples to Identify Novel Uses for Approved Drugs.

Teresa A Bennett, Ph.D., Sandra Sapia, MD., Pathologist, Daniel Primo, PhD, Lilia Suarez, Santiago Lago, PhD, Maria Matoses, PhD, Ana Espinosa, PhD, Consuelo Tudela, PhD, Elena Arroyo, PhD, William Coyt Jackson, PhD, Alex Okun, PhD, Horacio Hector Lopez, PhD, Isolde Gornemann, MD, Eva Diez, PhD, Josep M Roma, MD, Jose Luis Dapena, MD, Soledad Gallego Melcon, MD, Jose Sanchez de Toledo, MD, Ana Rosell, MD, Santiago Del Castillo, MD, PhD, Alicia Bailen, MD, Ana Isabel Heiniger, MD, Joaquin Díaz-Mediavilla, MD, Felipe Prosper, MD, Manuel Ramirez Sr., MD, PhD, Macarena Ortiz, MD, Marcos González, MD, Alfonso Dominguez-Gil, MD, Iñaki F Troconiz, MD, Fernando Rodriguez de Fonseca, MD, PhD, Enrique M Ocio, MD, Andrew Saunders, MD, Julieta Montejo, MD, Luis Caveda, PhD, Alberto Orfao, MD, PhD, Joan Ballesteros, PhD
Journal: Blood
Blood (2009) 114 (22): 4414.
https://doi.org/10.1182/blood.V114.22.4414.4414
Published: 2009
Journal Articles

Acadesine (Acadra‘) for Patients with Resistant/Relapsed Chronic B-Cell Lymphocytic Leukemia (B-CLL): A Multicentre Phase I/II Study.

Eric W Van Den Neste, MD, PhD, Eva Gonzalez-Barca, M.D., Ann Janssens, MD, Bruno Cazin, M.D., J. Pérez de Oteyza, M.D., Maria Jose Terol, MD, T. Auton, PhD, Andrew Saunders, M.D., Clara Campas, PhD
Journal: Blood
Blood (2009) 114 (22): 4405.
https://doi.org/10.1182/blood.V114.22.4405.4405
Published: 2009
Journal Articles

Effectiveness of Clofarabine in Elderly AML Patients with Adverse Cytogenetics Unfit for Intensive Chemotherapy.

Alan K. Burnett, M. Baccarani, Peter Johnson, John Yin, Andrew Saunders, Nigel Russell, Robert Hills
Journal: Blood
Blood (2006) 108 (11): 1985.
https://doi.org/10.1182/blood.V108.11.1985.1985
Published: 2006
Journal Articles

A Phase II Study (Biov-121) of Clofarabine Monotherapy First Line in Patients Aged 65 Years or Older with Acute Myeloid Leukemia for Whom Standard Intensive Chemotherapy Is Not Considered Suitable.

Alan K. Burnett, M. Baccarani, Peter Johnson, John Yin, Andrew Saunders, Nigel Russell, Robert K. Hills
Journal: Blood
Blood (2006) 108 (11): 425.
https://doi.org/10.1182/blood.V108.11.425.425
Published: 2006